What you’ll get each week:
Concise summaries of company announcements & press releases
Newly registered GLP-1 trials
Trial spotlight + mechanism notes
Timing: a concise weekly brief with links to sources so you can dig deeper
This is v1—we’ll expand based on what you need most. Replies and feedback are welcome.
About me: Michael Parker, MD / computer scientist; former Harvard Medical School faculty and founder of HMX. I’m building GLP-1 Observer to save you time in staying updated.